Expression of connective tissue growth factor and interleukin-11 in intratumoral tissue is associated with poor survival after curative resection of hepatocellular carcinoma

Molecular Biology Reports

Volumn 39, Issue 5, 2012, Pages 6001-6006

  Xiang, Zuo Lin ^a   Zeng, Zhao Chong ^a   Fan, Jia ^a   Tang, Zhao You ^a   Zeng, Hai Ying ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Connective tissue growth factor; Hepatocellular carcinoma; Interleukin 11; Prognosis; Tissue microarray

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; INTERLEUKIN 11; TRANSFORMING GROWTH FACTOR BETA1; CTGF PROTEIN, HUMAN; IL11 PROTEIN, HUMAN; TUMOR MARKER;

ARTICLE; CANCER GRADING; CANCER INVASION; CANCER PROGNOSIS; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; DISEASE ASSOCIATION; FOLLOW UP; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; LIVER RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIMARY TUMOR; PROGRESSION FREE SURVIVAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; KAPLAN MEIER METHOD; LIVER TUMOR; METABOLISM; PATHOLOGY; PROGNOSIS; TISSUE MICROARRAY;

CARCINOMA, HEPATOCELLULAR; CONNECTIVE TISSUE GROWTH FACTOR; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-11; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; PROGNOSIS; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84863768883     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1413-y     Document Type: Article

References (28)

1. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 20 02. CA Cancer J Clin 55:74-108
2. Venook AP, Papandreou C, Furuse J, de Guevara LL (2010) The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 15(Suppl 4):5-13
3. Gao Q, Qiu SJ, Fan J, Zhou J, Wang XY, Xiao YS, Xu Y, Li YW, Tang ZY (2007) Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25:2586-2593
4. Zuo GW, Kohls CD, He BC, Chen L, Zhang W, Shi Q, Zhang BQ, Kang Q, Luo J, Luo X, Wagner ER, Kim SH, Restegar F, Haydon RC, Deng ZL, Luu HH, He TC, Luo Q (2010) The CCN proteins: important signaling mediators in stem cell differentiation and tumorigenesis. Histol Histopathol 25:795-806
5. Chien W, O'Kelly J, Lu D, Leiter A, Sohn J, Yin D, Karlan B, Vadgama J, Lyons KM, Koeffler HP (2011) Expression of connective tissue growth factor (CTGF/CCN2) in breast cancer cells is associated with increased migration and angiogenesis. Int J Oncol 38:1741-1747
6. Mao Z, Ma X, Rong Y, Cui L, Wang X, Wu W, Zhang J, Jin D (2011) Connective tissue growth factor enhances the migration of gastric cancer through downregulation of E-cadherin via the NFjB pathway. Cancer Sci 102:104-110
7. Cui L, Zhang Q, Mao Z, Chen J, Wang X, Qu J, Zhang J, Jin D (2011) CTGF is overexpressed in papillary thyroid carcinoma and promotes the growth of papillary thyroid cancer cells. Tumour Biol 32:721-728
8. Perera M, Tsang CS, Distel RJ, Lacy JN, Ohno-Machado L, Ricchiuti V, Samaranayake LP, Smejkal GB, Smith MG, Trachtenberg AJ, Kuo WP (2010) TGF-beta1 interactome: metastasis and beyond. Cancer Genomics Proteomics 7:217-229
9. Howlett M, Giraud AS, Lescesen H, Jackson CB, Kalantzis A, Van Driel IR, Robb L, Van der Hoek M, Ernst M, Minamoto T, Boussioutas A, Oshima H, Oshima M, Judd LM (2009) The interleukin-6 family cytokine interleukin-11 regulates homeostatic epithelial cell turnover and promotes gastric tumor development. Gastroenterology 136:967-977
10. Yoshizaki A, Nakayama T, Yamazumi K, Yakata Y, Taba M, Sekine I (2006) Expression of interleukin (IL)-11 and IL-11 receptor in human colorectal adenocarcinoma: IL-11 up-regulation of the invasive and proliferative activity of human colorectal carcinoma cells. Int J Oncol 29:869-876
11. Poon RT, Ng IO, Lau C, Yu WC, Yang ZF, Fan ST, Wong J (2002) Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study. J Clin Oncol 20:1775-1785
12. Xiang ZL, Zeng ZC, Tang ZY, Fan J, Zhuang PY, Liang Y, Tan YS, He J (2009) Chemokine receptor CXCR4 expression in hepatocellular carcinoma patients increases the risk of bone metastases and poor survival. BMC Cancer 9:176
13. Xiang ZL, Zeng ZC, Tang ZY, Fan J, Sun H, Wu W, Tan Y (2009) Increased expression of vascular endothelial growth factor- C and nuclear CXCR4 in hepatocellular carcinoma is correlated with lymph node metastasis and poor outcome. Cancer J 15:519-525
14. Xiang ZL, Zeng ZC, Tang ZY, Fan J, Sun HC, Tan YS (2011) Expression of cytokeratin 19 and matrix metalloproteinase 2 predicts lymph node metastasis in hepatocellular carcinoma. Mol Biol Rep 38:3531-3539
15. Xiang ZL, Zeng ZC, Fan J, Tang ZY, He J, Zeng HY, Chang JY (2011) The expression of HIF-1a in primary hepatocellular carcinoma and its correlation with radiotherapy response and clinical outcome. Mol Biol Rep. doi: 10.1007/s11033-011-0949-1
16. Xiang ZL, Zeng ZC, Fan J, Tang ZY, Zeng HY, Gao DM (2011) Gene Expression profiling of fixed tissues identified HIF-1{alpha}, VEGF, and MMP-2 as biomarkers of lymph node metastasis in hepatocellular carcinoma. Clin Cancer Res 17:5463-5472
17. Qian YB, Zhang JB, Wu WZ, Fang HB, Jia WD, Zhuang PY, Zhang BH, Pan Q, Xu Y, Wang L, Tang ZY, Sun HC (2006) P48 is a predictive marker for outcome of postoperative interferonalpha treatment in patients with hepatitis B virus infection-related hepatocellular carcinoma. Cancer 107:1562-1569
18. Lin BR, Chang CC, Che TF, Chen ST, Chen RJ, Yang CY, Jeng YM, Liang JT, Lee PH, Chang KJ, Chau YP, Kuo ML (2005) Connective tissue growth factor inhibits metastasis and acts as an independent prognostic marker in colorectal cancer. Gastroenterology 128:9-23
19. Vagenas K, Spyropoulos C, Gavala V, Tsamandas AC (2007) TGFbeta1, TGFbeta2, and TGFbeta3 protein expression in gastric carcinomas: correlation with prognostics factors and patient survival. J Surg Res 139:182-188
20. Yamazumi K, Nakayama T, Kusaba T, Wen CY, Yoshizaki A, Yakata Y, Nagayasu T, Sekine I (2006) Expression of interleukin- 11 and interleukin-11 receptor alpha in human colorectal adenocarcinoma; immunohistochemical analyses and correlation with clinicopathological factors. World J Gastroenterol 12:317-321
21. Mazzocca A, Fransvea E, Dituri F, Lupo L, Antonaci S, Giannelli G (2010) Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumorstroma cross-talk and tumor progression in hepatocellular carcinoma. Hepatology 51:523-534
22. Bennewith KL, Huang X, Ham CM, Graves EE, Erler JT, Kambham N, Feazell J, Yang GP, Koong A, Giaccia AJ (2009) The role of tumor cell-derived connective tissue growth factor (CTGF/ CCN2) in pancreatic tumor growth. Cancer Res 69:775-784
23. Koliopanos A, Friess H, di Mola FF, Tang WH, Kubulus D, Brigstock D, Zimmermann A, Büchler MW (2002) Connective tissue growth factor gene expression alters tumor progression in esophageal cancer. World J Surg 26:420-427
24. Xie D, Yin D, Wang HJ, Liu GT, Elashoff R, Black K, Koeffler HP (2004) Levels of expression of CYR61 and CTGF are prognostic for tumor progression and survival of individuals with gliomas. Clin Cancer Res 10:2072-2081
25. Lin BR, Chang CC, Chen RJ, Jeng YM, Liang JT, Lee PH, Chang KJ, Kuo ML (2011) Connective tissue growth factor acts as a therapeutic agent and predictor for peritoneal carcinomatosis of colorectal cancer. Clin Cancer Res 17:3077-3088
26. Xiang ZL, Zeng ZC, Tang ZY, Fan J, He J, Zeng HY, Zhu XD (2011) Potential prognostic biomarkers for bone metastasis from hepatocellular carcinoma. Oncologist 16:1028-1039
27. Wang GB, Zhou XY, Yuan T, Xie J, Guo LP, Gao N, Wang XQ (2010) Significance of serum connective tissue growth factor in patients with hepatocellular carcinoma and relationship with angiogenesis. World J Surg 34:2411-2417
28. Hanavadi S, Martin TA, Watkins G, Mansel RE, Jiang WG (2006) Expression of interleukin 11 and its receptor and their prognostic value in human breast cancer. Ann Surg Oncol 13:802-808